FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
about
Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cellsA novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes.Silencing of Wnt10B reduces viability of heptocellular carcinoma HepG2 cells.The effect of heterogeneous Transcription Start Sites (TSS) on the translatome: implications for the mammalian cellular phenotype.B7-H3 protein expression in a murine model of osteosarcoma.Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancerMammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell InvasionThe four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.The adolescent and young adult with cancer: state of the art -- bone tumors.Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
P2860
Q21132015-49E88251-66CC-4D14-A8DB-1621EE6CB71BQ35207651-A33375E7-5DA2-448A-8575-6FFD5A6DE0C2Q35625523-6755DF14-9CF8-424A-B2A3-31A27ECA4457Q35744757-6D12F2E9-3A18-440F-B045-D47306F56232Q35847578-184E0426-7D28-4D52-942D-D0920D334B5DQ37001496-40BE54C9-7B69-46E3-B684-E177AD5163E0Q37003274-5C42B626-34CC-4D3D-8ABB-9F34D0C2823BQ37065685-AE047AD3-7929-4CFB-A60A-51C31C89EC7CQ37151504-D035435F-C07C-4885-8A4A-07633A59AD05Q38108248-3236EEAD-1825-48F5-AB81-13F8572FB6FBQ38285398-3E5D57CE-0ED8-49B3-94A1-FE5361ABA2C7Q38714711-3F0D852E-31D4-4265-B40E-F75450CE3B78Q38804262-D1D61FD8-C870-44D5-ACBA-832B6CD501D5
P2860
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@ast
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@en
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@nl
type
label
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@ast
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@en
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@nl
prefLabel
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@ast
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@en
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@nl
P2093
P2860
P1433
P1476
FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
@en
P2093
Caroline Marty
Fernando Lecanda
François-Xavier Dieudonné
Judith Müller
Julia Brun
Olivia Fromigué
Pierre J Marie
Roland Schüle
P2860
P304
P356
10.1371/JOURNAL.PONE.0055034
P407
P577
2013-01-28T00:00:00Z